“…Those included reports of experimental exposure studies and also studies of populations with ambient or occupational exposures. Another 12 reports described the clinical use of parenteral MTBE for dissolution of cholesterol gall stones (Allen et al, 1985;Di Padova et al, 1986;Hellstern et al, 1990;Leuschner et al, 1991;McNulty et al, 1991;Saraya, Rai, and Tandon, 1990;Neoptolemos et al, 1990;Ponchon, Baroud, Pujol et al, 1988;Murray, Laferla, and Fullarton, 1988;Brandon et al, 1988 Simunic, and Radanovic, 1992;Thistle et al, 1989). Although the exposure route in these studies differed from that in the occupational, ambient and experimental exposure studies, we anticipated that the much greater administered parenteral doses might provide insight into the physiological effects of acute MTBE exposure.…”